the influence of silica pore size and particle size on ... 2012... · pore size columns, ... please...

1
Particle size and pore size of silica are very important parameters of a reversed phase column for HPLC analysis. Small particle sizes, less than 3 μm and including sub-2μm, have been widely used for achieving high performance and fast separations. One additional factor that should be considered is the pore size of the silica particle. Normally you use column packings with small pores (60-120Å) for small molecules (less than 5000 Da), use 150-300Å for peptides and low molecular weight proteins and use large pore sizes (1000Å-4000Å) for very high molecular weight proteins and vaccines. A small protein, such as insulin with a molecular weight of about 5800 Da could potentially be analyzed on columns with small pores or slightly larger pores. To maximize efficiency smaller particle sizes with an optimum pore size should be selected. An insulin regulatory method (USP) with an isocratic mobile phase was used in this study of optimum pore and particle size. The performance and resolution is compared among columns with different pore size including 80Å, 95Å, 120Å, 170Å and 300Å and as well as different particle sizes including 1.8μm, 2.7μm, 3.5μm and 5μm. These choices also include different particle types, including both superficially porous and totally porous particles. The end result of the work shown here are recommendations for achieving the highest efficiency and resolution while still meeting the requirements of the regulatory methods. Columns with a small a pore size, <100Å did not provide the best results for insulin, because of the restricted access to the bonded phase in the pores of these columns. Columns with a larger pore size, >100Å, such as the Poroshell 120, Agilent TC-C18(2), and 300SB-C18 provided much higher efficiency and lower tailing factors. A pore size as large as 300Å was not needed for an efficient separation of insulin. The intermediate pore size columns, the Poroshell 120 and TC-C18 (2) columns were suitable and would therefore be a good choice for separations of other small proteins or peptide mapping. The smaller particle sizes provided the highest efficiencies. The Poroshell 120 columns had a 2.7μm particle size with a pore size of 120Å and were suitable for the highly efficient analysis of insulin. [1] China Pharmacopoeia (2010 edition), insulin, page. 845 – 846. [2] The United States Pharmacopoeia USP 31 (vol 2) – Insulin, page. 2403 – 2404. [3] Phu T Duong, Analysis of Oxidized Insulin chains using Reversed Phase Agilent ZORBAX RRHD 300 SB- C18, Agilent application note, 5990-7988EN To access Agilent’s Literature Library for application notes, visit us online at www.agilent.com/chem Results and Discussion Conclusions For More Information Please leave your business card to receive a reprint of this poster Pittcon 2012 Orlando, Florida March 13, 2012 1100-4P The influence of silica pore size and particle size on insulin - a small molecule of protein separation Rongjie FU 1 , William LONG 2 , Anne MACK 2 and Maureen JOSEPH 2 1 Agilent Technologies (Shanghai) Co., Ltd, Shanghai, China 200131 2 Agilent Technologies, Inc. 2850 Centerville Rd. Wilmington, Del. USA 19808 Experimental Abstract All the columns explored in this paper were C18 columns, meeting pharmacopeia definitions for octadecyl silane (C18), chemically bonded to porous silica. HPLC Conditions Sample: Porcine insulin (NIFDC China) Columns: Agilent ZORBAX SB-C18, 4.6 x 150 mm, 5 μm (p/n 883975-902) ZORBAX Eclipse Plus C18, 4.6 x 150 mm, 5 μm (p/n 959993-902) ZORBAX 300SB-C18, 4.6 x 150 mm, 5 μm (p/n 883995-902) ZORBAX SB-C18, 4.6 x 100 mm, 3.5 μm (p/n 861953-902) ZORBAX Eclipse Plus C18, 4.6 x 100 mm, 3.5 μm (p/n 959961-902) ZORBAX SB-C18, 4.6 x 100 mm, 1.8 μm (p/n 828975-902) ZORBAX Eclipse Plus C18, 4.6 x 100 mm, 1.8 μm (p/n 959964-902) Agilent Poroshell 120 SB-C18, 4.6 x 100 mm, 2.7 μm (p/n 685975-902) Agilent Poroshell 120 EC-C18, 4.6 x 100 mm, 2.7 μm (p/n 695975-902) Agilent TC-C18(2), 4.6 x 150 mm, 5 μm (p/n 588935-902) System: Agilent 1200 SL LC with binary pump, thermostatted column compartment, high performance autosampler and diode array detector Mobile Phase: 74% A:26% B, where A: 0.2 mol/L sulfate (dissolve 28.4g anhydrous sodium sulfate in 1000 mL of water, pipet 2.7 mL of phosphoric acid into the solution and adjust with ethanolamine to pH 2.3, and mix) B: acetonitrile Flow Rate: 1.0 mL/min Injection Vol: 20 μL Temp: 40 °C Detector: UV 214 nm Reference The method for insulin was first run on four traditional columns with a 5 μm particle size, but with four different pore sizes. Insulin has the poorest performance both on the SB-C18, 5 μm and the Eclipse Plus C18, 5 μm columns with the smallest pore sizes of 80Å and 95Å. The Agilent ZORBAX 300SB-C18 column has the lowest surface area, but the retention is only slightly less than the small pore size columns. Once the insulin can access the pores and interact with all of the bonded phase in the pores it is better retained. This more efficient access is also seen in the improved peak shape, even on a non-endcapped bonded phase. The Agilent TC- C18(2) column has the highest surface area and the strongest retention, most likely due to accessing all the pores and retention increasing with this higher surface area of silica particles (290 m2/g). In these chromatograms the Poroshell 120 SB-C18 2.7um column provides 2X the efficiency of the 80Å SB-C18 1.8μm. This is due to the larger pore size and more rapid diffusion in the 120Å pores. Switching from the ZORBAX Eclipse Plus C18 to Poroshell 120 EC- C18 also provided an increase in efficiency with the change from 95Å to 120Å pore size. In addition, the peak shape of insulin on both Poroshell 120 columns was improved with greater access to the pores. In addition, the Poroshell 120 column provides higher efficiency than the 5um Agilent TC-C18 (2). The chromatogram shown on the TC-C18 (2) column is the one run with 27.5% organic in the mobile phase so that the retention times could be more closely matched. The improvement in the efficiency when comparing these two columns is due to the benefit of the smaller particle size with a larger pore size. The retention on the Agilent TC-C18(2) column is very long, at over 40 minutes, and not ideal. Therefore the retention is reduced from 44 minutes to 15 minutes by increasing the organic in the mobile phase by only 1.5% while still maintaining good peak shape and efficiency The insulin method was run on 5 μm, 3.5 μm, and 1.8 μm Agilent ZORBAX SB-C18 columns and Agilent ZORBAX Eclipse Plus C18 columns. The data demonstrate improved efficiency using the smaller 1.8 μm particle columns. While these columns are not the ideal pore size columns, efficiency should still be expected to improve with smaller particle sizes, as it does here with insulin. Results and Discussion Results and Discussion Influence of silica pore size, 5μm particles min 10 20 30 40 50 mAU 0 25 50 75 100 125 150 min 10 20 30 40 50 min 10 20 30 40 50 mAU 0 50 100 150 200 250 min 10 20 30 40 50 mAU 0 50 100 150 200 250 mAU 0 100 200 300 400 500 80Å Agilent ZORBAX SB-C18 4.6X150mm, 5um 1 2 1 2 1 2 1 2 N 1 = 1776 Tf 1 = 1.7 N 2 = 2774 Tf 2 = 2.0 Rs=3.4 1. Porcine insulin 2. A - 21 desamido insulin N 1 = 1845 Tf 1 = 1.2 N 2 = 2489 Tf 2 = 1.2 Rs=3.1 N 1 = 5124 Tf 1 = 1.1 N 2 = 5870 Tf 2 = 1.0 Rs=4.5 N 1 = 4333 Tf 1 = 1.1 N 2 = 4709 Tf 2 = 1.0 Rs=3.9 95Å Agilent ZORBAX Eclipse Plus C18 4.6X150mm, 5um 170Å Agilent TC-C18(2) 4.6X150mm, 5um 300Å Agilent ZORBAX 300SB-C18 - , 4.6X150mm, 5um min 10 20 30 40 50 60 mAU - 25 0 25 50 75 100 125 150 175 min 10 20 30 40 50 60 mAU 0 100 200 300 400 500 N 1 = 5124 Tf 1 = 1.1 N 2 = 5870 Tf 2 = 1.0 Rs=4.5 1 1 Porcine insulin 2 A-21 desamido insulin 2 N 1 = 4527 Tf 1 = 1.0 N 2 = 4904 Tf 2 = 1.0 Rs=3.4 1 2 26%ACN 27.5%ACN Influence of silica particle size Agilent ZORBAX SB-C18 4.6x150mm, 5 um 4.6x100mm, 1.8 um min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 50 100 150 200 250 300 min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 500 4.6x100mm, 3.5 um 1 2 1 2 1 2 N 1 = 1776 Tf 1 = 1.7 N 2 = 2774 Tf 2 = 2.0 Rs=3.4 N 1 = 1806 Tf 1 = 1.2 Rs=2.8 Rs=4.9 1. Porcine insulin Agilent ZORBAX Plus C18 4.6x150mm, 5um Agilent ZORBAX Plus C18, 4.6x100mm, 3.5 um Agilent ZORBAX Plus C18, min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 50 100 150 200 250 300 min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 500 600 1 2 1 2 1 2 Rs=6.0 Rs=3.0 Rs=3.1 1. Porcine insulin Comparison between superficially porous and totally porous columns N 1 = 5215 Tf 1 =1.4 N 2 = 6691 N 2 = 1.2 Agilent ZORBAX Eclipse Plus C18 4.6x100mm, 1.8um Agilent Poroshell 120 SB-C18 4.6x100mm, 2.7um Agilent ZORBAX SB-C18 4.6x100mm, 1.8um min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 500 min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 500 600 min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 500 600 min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 500 600 N 1 = 10860 Tf 1 = 1.1 N 2 = 12377 Tf 2 = 1.0 N 1 =7854 Tf 1 =1.4 N 2 = 9434 Tf 2 = 1.1 N 1 = 9768 Tf 1 = 1.0 N 2 = 10710 Tf 2 = 1.0 1 Porcine insulin 2 A21 desamido insulin 255 bar 190 bar 237 bar 198 bar min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 500 600 700 min 2.5 5 7.5 10 12.5 15 17.5 20 22.5 mAU 0 100 200 300 400 500 600 700 N 1 =10860 Tf 1 = 1.1 N 2 = 12377 Tf 2 = 1.0 Poroshell 120 SB-C18 4.6x100mm, 2.7 um Rs=6.6 N 1 = 4527 Tf 1 = 1.0 N 2 = 4904 Tf 2 = 1.0 Rs=3.4 1 2 Agilent TC-C18(2) 4.6x150mm, 5 um 1 2 27.5%ACN 26%ACN 1 Porcine insulin Agilent Poroshell 120 EC-C18 4.6x100mm, 2.7um 2 A21 desamido insulin 2. A21 desamido insulin Agilent ZORBAX SB-C18 N 2 = 2172 Tf 2 = 1.2 Agilent ZORBAX SB-C18 Tf 2 = 1.2 N 2 = 6691 N 1 = 5215 Tf 1 = 1.4 4.6x100mm, 1.8 um 2 A21 desamido insulin N 1 = 1845 Tf 1 = 1.2 N 1 = 2157 Tf 1 = 1.2 N 1 = 7854 Tf 1 = 1.4 Tf 2 = 1.2 N 2 = 2489 Tf 2 = 1.2 N 2 = 2604 Tf 2 = 1.1 N 2 = 9434 Agilent TC-C18(2) 4.6X150mm, 5um Agilent TC-C18(2) 4.6X150mm, 5um

Upload: dangliem

Post on 05-Jun-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

Particle size and pore size of silica are very important

parameters of a reversed phase column for HPLC

analysis. Small particle sizes, less than 3 µm and

including sub-2µm, have been widely used for achieving

high performance and fast separations. One additional

factor that should be considered is the pore size of the

silica particle. Normally you use column packings with

small pores (60-120Å) for small molecules (less than

5000 Da), use 150-300Å for peptides and low molecular

weight proteins and use large pore sizes (1000Å-4000Å)

for very high molecular weight proteins and vaccines.

A small protein, such as insulin with a molecular

weight of about 5800 Da could potentially be analyzed

on columns with small pores or slightly larger pores. To

maximize efficiency smaller particle sizes with an

optimum pore size should be selected. An insulin

regulatory method (USP) with an isocratic mobile

phase was used in this study of optimum pore and

particle size. The performance and resolution is

compared among columns with different pore size

including 80Å, 95Å, 120Å, 170Å and 300Å and as well as

different particle sizes including 1.8µm, 2.7µm, 3.5µm

and 5µm. These choices also include different particle

types, including both superficially porous and totally

porous particles. The end result of the work shown

here are recommendations for achieving the highest

efficiency and resolution while still meeting the

requirements of the regulatory methods.

• Columns with a small a pore size, <100Å did not

provide the best results for insulin, because of the

restricted access to the bonded phase in the pores of

these columns.

• Columns with a larger pore size, >100Å, such as the

Poroshell 120, Agilent TC-C18(2), and 300SB-C18

provided much higher efficiency and lower tailing

factors. A pore size as large as 300Å was not needed

for an efficient separation of insulin. The intermediate

pore size columns, the Poroshell 120 and TC-C18 (2)

columns were suitable and would therefore be a good

choice for separations of other small proteins or peptide

mapping.

• The smaller particle sizes provided the highest

efficiencies. The Poroshell 120 columns had a 2.7µm

particle size with a pore size of 120Å and were suitable

for the highly efficient analysis of insulin.

[1] China Pharmacopoeia (2010 edition), insulin, page. 845 – 846. [2] The United States Pharmacopoeia USP 31 (vol 2) – Insulin, page. 2403 – 2404. [3] Phu T Duong, Analysis of Oxidized Insulin chains using Reversed Phase Agilent ZORBAX RRHD 300 SB-C18, Agilent application note, 5990-7988EN To access Agilent’s Literature Library for application notes, visit us online at www.agilent.com/chem

Results and Discussion Conclusions

For More Information

Please leave your business card to receive a reprint of this poster

Pittcon 2012

Orlando, Florida

March 13, 2012

1100-4P

The influence of silica pore size and particle size on insulin - a small molecule of protein separation Rongjie FU1, William LONG2, Anne MACK2 and Maureen JOSEPH2 1Agilent Technologies (Shanghai) Co., Ltd, Shanghai, China 200131 2Agilent Technologies, Inc. 2850 Centerville Rd. Wilmington, Del. USA 19808

Experimental Abstract

All the columns explored in this paper were C18

columns, meeting pharmacopeia definitions for

octadecyl silane (C18), chemically bonded to porous

silica.

HPLC Conditions

Sample: Porcine insulin (NIFDC China)

Columns: Agilent ZORBAX SB-C18, 4.6 x 150 mm, 5 µm

(p/n 883975-902)

ZORBAX Eclipse Plus C18, 4.6 x 150 mm, 5 µm

(p/n 959993-902)

ZORBAX 300SB-C18, 4.6 x 150 mm, 5 µm

(p/n 883995-902)

ZORBAX SB-C18, 4.6 x 100 mm, 3.5 µm

(p/n 861953-902)

ZORBAX Eclipse Plus C18, 4.6 x 100 mm, 3.5 µm

(p/n 959961-902)

ZORBAX SB-C18, 4.6 x 100 mm, 1.8 µm

(p/n 828975-902)

ZORBAX Eclipse Plus C18, 4.6 x 100 mm, 1.8 µm

(p/n 959964-902)

Agilent Poroshell 120 SB-C18, 4.6 x 100 mm, 2.7 µm

(p/n 685975-902)

Agilent Poroshell 120 EC-C18, 4.6 x 100 mm, 2.7 µm

(p/n 695975-902)

Agilent TC-C18(2), 4.6 x 150 mm, 5 µm

(p/n 588935-902)

System: Agilent 1200 SL LC with binary pump,

thermostatted column compartment, high performance

autosampler and diode array detector

Mobile Phase: 74% A:26% B, where A: 0.2 mol/L sulfate

(dissolve 28.4g anhydrous sodium sulfate in 1000 mL of

water, pipet 2.7 mL of phosphoric acid into the solution

and adjust with ethanolamine to pH 2.3, and mix) B:

acetonitrile

Flow Rate: 1.0 mL/min

Injection Vol: 20 µL

Temp: 40 °C

Detector: UV 214 nm

Reference

The method for insulin was first run on four traditional

columns with a 5 μm particle size, but with four different

pore sizes.

Insulin has the poorest performance both on the SB-C18, 5

μm and the Eclipse Plus C18, 5 μm columns with the smallest

pore sizes of 80Å and 95Å. The Agilent ZORBAX 300SB-C18

column has the lowest surface area, but the retention is only

slightly less than the small pore size columns. Once the

insulin can access the pores and interact with all of the

bonded phase in the pores it is better retained. This more

efficient access is also seen in the improved peak shape,

even on a non-endcapped bonded phase. The Agilent TC-

C18(2) column has the highest surface area and the

strongest retention, most likely due to accessing all the

pores and retention increasing with this higher surface area

of silica particles (290 m2/g).

In these chromatograms the Poroshell 120 SB-C18 2.7um column

provides 2X the efficiency of the 80Å SB-C18 1.8µm. This is due to

the larger pore size and more rapid diffusion in the 120Å pores.

Switching from the ZORBAX Eclipse Plus C18 to Poroshell 120 EC-

C18 also provided an increase in efficiency with the change from

95Å to 120Å pore size. In addition, the peak shape of insulin on

both Poroshell 120 columns was improved with greater access to

the pores.

In addition, the Poroshell 120 column provides higher efficiency

than the 5um Agilent TC-C18 (2). The chromatogram shown on

the TC-C18 (2) column is the one run with 27.5% organic in the

mobile phase so that the retention times could be more closely

matched. The improvement in the efficiency when comparing

these two columns is due to the benefit of the smaller particle

size with a larger pore size.

The retention on the Agilent TC-C18(2) column is very long, at

over 40 minutes, and not ideal. Therefore the retention is

reduced from 44 minutes to 15 minutes by increasing the

organic in the mobile phase by only 1.5% while still

maintaining good peak shape and efficiency

The insulin method was run on 5 μm, 3.5 μm, and 1.8 μm

Agilent ZORBAX SB-C18 columns and Agilent ZORBAX Eclipse

Plus C18 columns. The data demonstrate improved efficiency

using the smaller 1.8 μm particle columns. While these

columns are not the ideal pore size columns, efficiency should

still be expected to improve with smaller particle sizes, as it

does here with insulin.

Results and Discussion Results and Discussion

Influence of silica pore size, 5µm

particles

min 10 20 30 40 50

mAU

0

25

50

75

100

125

150

min 10 20 30 40 50

min 10 20 30 40 50

mAU

0

50

100

150

200

250

min 10 20 30 40 50

mAU

0

50

100

150

200

250

mAU

0

100

200

300

400

500

80Å Agilent ZORBAX SB-C18

4.6X150mm, 5um

1

2

1

2

1

2

1

2

N 1 = 1776 Tf 1 = 1.7 N 2 = 2774

Tf 2 = 2.0

Rs=3.4

1. Porcine insulin 2. A - 21 desamido insulin

N 1 = 1845 Tf 1 = 1.2

N 2 = 2489 Tf 2 = 1.2

Rs=3.1

N 1 = 5124 Tf 1 = 1.1 N 2 = 5870

Tf 2 = 1.0

Rs=4.5

N 1 = 4333 Tf 1 = 1.1

N 2 = 4709 Tf 2 = 1.0

Rs=3.9

95Å Agilent ZORBAX Eclipse Plus C18

4.6X150mm, 5um

170Å Agilent TC-C18(2) 4.6X150mm, 5um

300Å Agilent ZORBAX 300SB-C18 - ,

4.6X150mm, 5um

min 10 20 30 40 50 60

mAU

- 25

0

25

50

75

100

125

150

175

min 10 20 30 40 50 60

mAU

0

100

200

300

400

500

N 1 = 5124 Tf 1 = 1.1

N 2 = 5870 Tf 2 = 1.0

Rs=4.5

1 1 Porcine insulin 2 A-21 desamido insulin

2

N 1 = 4527 Tf 1 = 1.0

N 2 = 4904 Tf 2 = 1.0

Rs=3.4

1

2

26%ACN

27.5%ACN

Influence of silica particle size

Agilent ZORBAX SB-C18

4.6x150mm, 5 um

4.6x100mm, 1.8 um

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

50

100

150

200

250

300

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

100

200

300

400

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

100

200

300

400

500

4.6x100mm, 3.5 um

1

2

1

2

1

2

N1= 1776

Tf1= 1.7 N2= 2774 Tf2= 2.0

Rs=3.4

N1= 1806

Tf1= 1.2

Rs=2.8

Rs=4.9

1. Porcine insulin

Agilent ZORBAX Plus C18

4.6x150mm, 5um

Agilent ZORBAX Plus C18,

4.6x100mm, 3.5 um

Agilent ZORBAX Plus C18,

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

50

100

150

200

250

300

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

100

200

300

400

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

100

200

300

400

500

600

1

2

1

2

1

2

Rs=6.0

Rs=3.0

Rs=3.1

1. Porcine insulin

Comparison between superficially porous

and totally porous columns

N 1 = 5215 Tf 1 =1.4 N 2 = 6691

N 2 = 1.2

Agilent ZORBAX Eclipse Plus C18 4.6x100mm, 1.8um

Agilent Poroshell 120 SB-C18 4.6x100mm, 2.7um

Agilent ZORBAX SB-C18

4.6x100mm, 1.8um

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

100

200

300

400

500

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0 100 200 300 400 500 600

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0 100 200 300 400 500 600

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0 100 200 300 400 500 600

N 1 = 10860 Tf 1 = 1.1 N 2 = 12377

Tf 2 = 1.0

N1=7854

Tf1=1.4 N2= 9434 Tf2= 1.1

N1= 9768

Tf1= 1.0 N2= 10710 Tf2= 1.0

1 Porcine insulin 2 A21 desamido insulin

255 bar

190 bar

237 bar

198 bar

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

100

200

300

400

500

600

700

min 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

100

200

300

400

500

600

700

N1=10860

Tf1= 1.1

N2 = 12377

Tf2 = 1.0

Poroshell 120 SB-C18

4.6x100mm, 2.7 um Rs=6.6

N1= 4527

Tf1= 1.0

N2= 4904 Tf2= 1.0

Rs=3.4

1

2

Agilent TC-C18(2) 4.6x150mm, 5 um

1

2

27.5%ACN

26%ACN

1 Porcine insulin

Agilent Poroshell 120 EC-C18

4.6x100mm, 2.7um

2 A21 desamido insulin

2. A21 desamido insulin

Agilent ZORBAX SB-C18

N2= 2172

Tf2= 1.2

Agilent ZORBAX SB-C18

Tf2= 1.2

N2= 6691 N1= 5215

Tf1= 1.4

4.6x100mm, 1.8 um

2 A21 desamido insulin N1= 1845

Tf1= 1.2

N1= 2157 Tf1= 1.2

N1= 7854

Tf1= 1.4

Tf2= 1.2

N2= 2489

Tf2= 1.2

N2= 2604

Tf2= 1.1

N2= 9434

Agilent TC-C18(2)

4.6X150mm, 5um

Agilent TC-C18(2)

4.6X150mm, 5um